Autoimmunity vs autoinflammation in Behcet's disease: Do we oversimplify a complex disorder?

Rheumatology

Volumn 45, Issue 12, 2006, Pages 1461-1465

  Direskeneli, H ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Adaptive; Behcet's disease; Innate; Pathogenesis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AUTOIMMUNITY; BEHCET DISEASE; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNITY; BACTERIAL INFECTIONS; BEHCET SYNDROME; HUMANS; INFLAMMATION;

EID: 33751435160     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel329     Document Type: Review

References (69)

1. Yazici H, Yurdakul S, Hamuryudan V. Behçet's Syndrome. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1998;7:26. 1-6.
2. DiIeskeneli H. Behcet's Disease: Review: infectious aetiology, new auto-antigens and HLA-B51. Ann Rheum Dis 2001;996-1002.
3. Yazici H. The place of Behçet's Syndrome among the autoimmune diseases. Intern Rev Immunol 1997;14:1-10.
4. Gul A. Behcet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005;4:81-3.
5. Yazici H, Fresko I. Behcet's disease and other autoinflammatory conditions: What's in a name? Clin Exp Rheumatol 2005;23(Suppl 38):S1-2.
6. Wakabayashi T, Morimura Y, Miyamato Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocular Immunol Inflamm 2003; 11:277-86.
7. Yoshida A, Kawashima H, Motoyama Y et al. Comparison of patients with Behcet's disease in 1980s and 1990s. Ophthalmology 2004;111:810-5.
8. Tugal-Tutkun I, Onal S, Altan-Yaycioǧlu R, Altunbas HH, Urgancioǧlu M. Uveitis in Behcet's Disease: An analysis of 880 patients. Am J Ophthalmol 2004;138:373-80.
9. Seyahi E, Ugurlu S, Seyahi N et al. A survey of socioeconomic status in Behoet's Syndrome. XI International Conference on Behcet's disease. Clin Exp Rheumatol 2004;22(Suppl 34):S88, A27 (abstract).
10. The Behcet's Disease Research Committee of Japan. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease - a multicenter study. J Rheumatol 1989;16:506-11.
11. Mumcu G, Ergun T, Inanc N et al. Oral health is impaired in Behcet's disease and is associated with disease severity. Rheumatology (Oxford) 2004;43:1028-33.
12. Hatemi G, Bahar H, Uysal S et al. The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis 2004;63:1450-2.
13. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL-6 and interferon-gamma by T cells from patients with Behcet's Disease. Cell Immunol 1992;140:410-9.
14. Mochizuki N, Suzuki N, Takeno M et al. Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a grampositive bacterium, Streptococcus sanguis. Eur J Immunol 1994;24:1536-43.
15. Cuchacovich M, Merino G, Yamamoto JH et al. Behcet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation. Clin Exp Rheumatol 2005;23(Suppl 38):S27-34.
16. Hirohata S, Hashimoto T. Abnormal T cell responses to bacterial superantigens in Behcet's disease (BD). Clin Exp Immunol 1998;112:17-24.
17. Kibaroglu A, Eksioglu-Demiralp E, Akoglu T, Direskeneli H. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behcet's disease. Clin Exp Rheumatol 2004;22(Suppl 34):S59-63.
18. Calguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet's disease. A randomized clinical trial. Arthritis Rheum 1996;39:2062-5.
19. Mumcu G, Ergun T, Elbir Y et al. Clinical and immunological effects of azithromycin in Behcet's disease. J Oral Pathol Med 2005;34:13-6.
20. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993;14:426-9.
21. Direskeneli H, Ekşioǧlu-Demiralp E, Kibaroǧlu A, Yavuz S, Ergun T, Akoglu T. Oligoclonal T cell expansions in patients with Behcet's Disease. Clin Exp Immunol 1999; 117:166-70.
22. Ekşioǧlu-Demiralp E, Kibaroǧlu A, Direskeneli H et al. Phenotypic characteristics of B cells in Behcet's Disease: Increased activity in B cell subsets. J Rheumatol 1999;26:526-32.
23. Direskeneli H, Keser G, D'Cruz D et al. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatology 1995;14:55-61.
24. Mor P, Weinberger A, Cohen IR. Identification of alpha-tropomyosin as a target self antigen in Behcet's syndrome. Eur J Immunol 2002;32:356-65.
25. Lee KH, Chong HS, Kim HS et al. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 2003;48:2025-35.
26. Lu Y, Ye P, Chen SL, Tan EM, Chan EK. Identification of kinectin as a novel Behcet's disease autoantigen. Arthritis Res Ther 2005;7:R1133-9.
27. Direskeneli H, Saruhan-Direskeneli G. The role of heatshock proteins in Behcet's disease. Clin Exp Rheumatol 2003;21(Suppl 30):S44-8.
28. Hasan A, Fortune F, Wilson A et al. Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996;347:789-94.
29. Kaneko S, Suzuki N, Yamashita N et al. Characterization of T cells specific for an epitope of human 60 kD heat shock protein (hsp) in patients with Behcet's disease in Japan. Clin Exp Immunol 1997;108:204-11.
30. Direskeneli H, Ekşioǧlu-Demiralp E, Yavuz S et al. T cell responses to 60/65 kD HSP derived peptides in Turkish Behcet's Disease patients. J Rheumatol 2000;27:708-13.
31. Nagafuchi H, Takeno M, Yoshikawa H et al. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease. Clin Exp Immunol 2005;139:363-70.
32. Saruhan-Direskeneli G, Celet B, Eksioglo-Demiralp E, Direskeneli H. Human HSP 60 peptide responsive T cell tines are similarly present in both Behcet's disease patients and healthy controls. Immunology Letters 2001;79:203-8.
33. Hu W, Hasan A, Wilson A et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol 1998;28:2444-55.
34. Stanford M, Whittall T, Bergmeier LA et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol 2004;137:201-28.
35. Yasuoka H, Okazaki Y, Kawakami Y et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet's disease. Arthritis Rheum 2004;50:3658-62.
36. Kurhan-Yavuz S, Direskeneli H, Bozkurt N et al. Anti-MHC autoimmunity in Behcet's disease: T cell response to an HLA-B derived peptide cross-reactive with retinal-S Ag in patients with uveitis. Clin Exp Immunol 2000;120:162-6.
37. Gul A, Uyar FA, Inanc M et al. A Weak association of HLA-B*2702 with Behcet's disease. Genes Immun 2002;3:368-72.
38. Saruhan-Direskeneli G, Uyar FA, Cefle A et al. Expression of KIR and C-type lectin receptors in Behcet's disease. Rheumatology (Oxford) 2004;43:423-7.
39. Stojanov S, Kastner DL. Familial autoinflammatory diseases: Genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005;17:586-99.
40. Ting JPY, Kastner DL, Hoffman HM. CATERPILLERs, pyrin and hereditery immunological disorders. Nat Rev Immunol 2006;6:183-95.
41. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behcet's disease and associated with vascular involvement. Clin Exp Rheumatol 2003;21(Suppl 30):S35-7.
42. Ergun T, Gurbuz O, Harvell J, Jorizzo J, White W. The histopathology of pathergy: A chronologic study of skin hyperreactivity in Behcet's disease. Int J Dermatol 1998;37:929-33.
43. Fresko I, Yazici H, Bayramicli M, Yurdakul S, Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behcet's syndrome. Ann Rheum Dis 1993;52:619-20.
44. Tung R, Uluhan A, Melikoǧlu M, Ozyazgan Y, Ozdoǧan H, Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet's syndrome. Clin Exp Rheumatol 2001;19(Suppl 24):S45-47.
45. Cakici N, Yazici H, Chamberlain MA et al. Response to intradermal injection of monosodium urate crystals in Behcet's syndrome. Ann Rheum Dis 1991;50:634-6.
46. Gogus F, Fresko I, Elbir Y, Eksioglu-Demiralp E, Direskeneli H. Oxidative burst response to monosodium urate crystals in patients with Behcet's syndrome. Clin Exp Rheumatol 2005;23(Suppl 38):S81-5.
47. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 2006;Jan 11 (eprint).
48. Musabak U, Sengul A, Oktenli C et al. Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol 2004;138:526-33.
49. Nathan C. Neutrophils and immunity: Challenges and opportunities. Nat Rev Immunol 2006;6:173-82.
50. Ekşioǧlu-Demiralp E, Direskeneli H, Kibaroǧlu A, Yavuz S, Ergun T, Akoǧlu T. Neutrophil activation in Behcet's Disease. Clin Exp Rheumatol 2001;19(Suppl 24):S19-24.
51. Martinon F, Agostini L, Meylan E, Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/Cryopyrin inflammasome. Curr Biol 2004;14:1929-34.
52. Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 2002;270:169-84.
53. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat-shock proteins, which deliver a partial maturation signal to dendritic cells and activate NF-kappa B pathway. Int Immunol 2000;12:1539-46.
54. Flohe SB, Brugemann J, Lendemans S et al. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol 2003;170:2340-8.
55. Elbir Y, Tulunay A, Özilhan G et al. Toll-like receptors in the etiopathogenesis of Behcet's disease. XI International Conference on Behcet's disease. Clin Exp Rheumatol 2004;22(Suppl 34):S93 (abst).
56. Hasan A, Sadoh D, Palmer R, Foo M, Marber M, Lehner T. The immune responses to human and microbial heat shock proteins in periodontal disease with and without coronary heart disease. Clin Exp Immunol 2005;142:585-94.
57. Harper L, Williams JM, Savage CO. The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis. Biochem Soc Trans 2004;32:502-6.
58. Inanc N, Mumcu G, Birtas E et al. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity. J Rheumatol 2005;32:287-91.
59. Mumcu G, Inanc N, Elbir Y, Ergun T, Yavuz S, Direskeneli H. Low serum mannose binding lectin levels predispose to S.mutans colonization in Behcet's disease. Clin Exper Rheumatol 2004;22(Suppl 34):S-93 (abst).
60. Mantas C, Direskeneli H, Oz D et al. IL-8 producing cells in Behcet's disease. Clin Exp Rheumatol 2000;18:249-51.
61. Keller M, Spanou Z, Schaerli P et al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol 2005;175:7678-86.
62. Münz C, Steinman RM, Fujii S. Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive responses. J Exp Med 2005;202:203-7.
63. Freysdottir J, Lau SH, Fortune F. Gamma delta+ T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1999; 118:451-7.
64. Ergun T, Ince U, Eksioglu-Demiralp E et al. Expression of 60 kD heat shock protein in mucocutaneous lesions in Behcet's Disease. J Am Acad Dermatol 2001;45:904-9.
65. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev in Immunol 2003;3:984-93.
66. Curnow SJ, Falciani F, Durrani OM et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci 2005;11:4251-9.
67. Aitman TJ. DNA microarrays in medical practice. Br Med J 2001;323:611-5.
68. Matzinger P. The danger model: A renewed sense of self Science 2002;296:301-5.
69. Medzhitov R, Janeway CAJr. Decoding the patterns of self and non-self by the innate immune system. Science 2002;296:298-300.